Helus Pharma, a clinical-stage pharmaceutical company, is developing novel serotonergic agonists.
6 reports, 3 independent
Updated Sep 27
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 6
- Developments
- 2
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Helus Pharma, a clinical-stage pharmaceutical company, is developing novel serotonergic agonists.
How it developed
Newest first. Tap a step to see who reported it.Suresh Durgam appointed to Helus Pharma's Scientific Advisory Board.1 source
Helus Pharma is developing novel serotonergic agonists.1 source